Summary workshop report: Facilitating oral product development and reducing regulatory burden through novel approaches to assess bioavailability/bioequivalence.

导出 OA

翻译打印收藏纠错

第一作者： James E,Polli

第一单位： University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA. jpolli@rx.umaryland.edu

作者： James E,Polli ^[1] ; Jack A,Cook ; Barbara M,Davit ; Paul A,Dickinson ; Domenick,Argenti ; Nancy,Barbour ; Alfredo,García-Arieta ; Jean-Marie,Geoffroy ; Kerry,Hartauer ; Shoufeng,Li ; Amitava,Mitra ; Francis X,Muller ; Vivek,Purohit ; Manuel,Sanchez-Felix ; John W,Skoug ; Kin,Tang

作者单位： University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA. jpolli@rx.umaryland.edu ^[1]

主题词投药, 口服(Administration, Oral);生物利用度(Biological Availability);药物设计(Drug Design);治疗等效(Therapeutic Equivalency)

DOI 10.1208/s12248-012-9376-z

PMID 22684402

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交